Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder
2011

Genetic Variants in Glutamate Receptors Linked to Schizophrenia and Bipolar Disorder

Sample size: 1304 publication 10 minutes Evidence: moderate

Author Information

Author(s): Frank René A. W. McRae, Allan F. Pocklington, Andrew J. van de Lagemaat, Pau Navarro, Mike D. R. Croning, Noboru H. Komiyama, Sophie J. Bradley, R. A. John Challiss, J. Douglas Armstrong, Robert D. Finn, Mary P. Malloy, Alan W. MacLean, Sarah E. Harris, John M. Starr, Sanjeev S. Bhaskar, Eleanor K. Howard, Sarah E. Hunt, Alison J. Coffey, Venkatesh Ranganath, Panos Deloukas, Jane Rogers, Walter J. Muir, Ian J. Deary, Douglas H. Blackwood, Peter M. Visscher, Seth G. N. Grant

Primary Institution: Wellcome Trust Sanger Institute

Hypothesis

Do genetic variations in glutamate receptors contribute to the risk of schizophrenia and bipolar disorder?

Conclusion

The study suggests that multiple genetic coding variants in glutamate receptors may play a role in the development of schizophrenia and bipolar disorders.

Supporting Evidence

  • 62 different coding variants were identified in the study.
  • 24 mutations were found solely in either the schizophrenia or bipolar disorder cohort.
  • Individuals with multiple nsSNPs showed increased genetic load contributing to disease.
  • Significant association was found with the ten genes selected for sequencing.
  • GRM1 was identified as a potential new genetic link to schizophrenia and bipolar disorder.

Takeaway

Scientists looked at genes related to brain signaling in people with schizophrenia and bipolar disorder and found some changes that might help explain these conditions.

Methodology

The study involved re-sequencing the exons of ten glutamatergic hub genes in case and control samples.

Potential Biases

Potential bias due to the selection of specific genetic variants and the population studied.

Limitations

The study may not account for all genetic factors contributing to schizophrenia and bipolar disorder.

Participant Demographics

Caucasian individuals diagnosed with schizophrenia, bipolar disorder, and healthy controls.

Statistical Information

P-Value

0.0034

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0019011

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication